|
Index of reports
> Cases with Sepsis (184)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include sepsis. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 184 Next >>
Possible Cytarabine side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male, weighing 95.8 kg (210.8 pounds)
Reactions: Abdominal Pain, Hypotension, Pancytopenia, Ascites, Faecaloma, Diarrhoea, Sepsis, Colitis, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 25 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-04
Clofarabine
Dosage: 25 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-03
Cytarabine
Dosage: 750 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-04
Cytarabine
Dosage: 750 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-03
Idarubicin HCL
Dosage: 7.5 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-02
Idarubicin HCL
Dosage: 7.5 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-01
Other drugs received by patient: Vancomycin; Metronidazole; Piritramide; Enoxaparin Sodium; Zofran; Clonazepam; Sodium Chloride; Ciprofloxacin; Acyclovir; Ringer; Levothyroxine Sodium; Potassium Chloride; Ceftazidime; Noxafil
Possible Cytarabine side effects in 64 year old male
Reported by a physician from Germany on 2012-08-21
Patient: 64 year old male, weighing 105.5 kg (232.1 pounds)
Reactions: Multi-Organ Failure, Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Clofarabine
Dosage: 54.53 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-08
End date: 2012-08-11
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Meropenem
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 108.0 kg (237.6 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Bronchopulmonary Aspergillosis, Haemoptysis, Tinea Cruris, Haemorrhage Intracranial, Transfusion Reaction, Constipation, Mucosal Inflammation, Oesophageal Candidiasis, Respiratory Failure, Diarrhoea, Oral Candidiasis, Sepsis, Blood Creatinine Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Other drugs received by patient: Omeprazole; Oxycontin; Neupogen; Multi-Vitamin; Biotene; Oxycodone HCL; Platelets; Acyclovir; Albuterol; Allopurinol; Carvedilol; Hydroxyurea; Docusate; Spiriva; Bactrim
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Off Label Use, Sepsis, Cerebral Ischaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: on day 1 over 15-30 minutes
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Possible Cytarabine side effects in 14 year old male
Reported by a physician from United States on 2012-08-20
Patient: 14 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Dyspnoea, Hypotension, Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-10
Cytarabine
Dosage: 70 mg, cyclic
Start date: 2012-08-09
End date: 2012-08-09
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Possible Cytarabine side effects in 44 year old female
Reported by a physician from France on 2012-08-17
Patient: 44 year old female
Reactions: Lung Disorder, Gastrointestinal Haemorrhage, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia
Drug(s) suspected as cause:
Cytarabine
Dosage: 348 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-22
End date: 2008-07-28
Daunorubicin HCL
Dosage: 104.4 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-22
End date: 2008-07-24
Mylotarg
Dosage: 10.4 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-25
End date: 2008-07-25
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-08-16
Patient: male, weighing 66.0 kg (145.2 pounds)
Reactions: Bronchopulmonary Aspergillosis, Dyspnoea, Respiratory Failure, Sepsis, Hepatic Lesion
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 18.48 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-03
Cytarabine
Dosage: 369.66 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-03
Idarubicin HCL
Dosage: 22.18 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-03
Other drugs received by patient: Piperacillin W
Possible Cytarabine side effects in 66 year old male
Reported by a physician from United States on 2012-08-14
Patient: 66 year old male
Reactions: Sepsis, Melaena, Decreased Appetite, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 3360 mg, (total)
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-25
Daunorubicin HCL
Dosage: 435 mg, (total)
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-25
Sprycel
Dosage: 1200 mg, (total)
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-25
End date: 2012-06-12
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-14
Patient:
Reactions: Multi-Organ Failure, Sepsis, Cerebral Ischaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: on day 1 over 15-30 minutes
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from Belgium on 2012-08-10
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Pericarditis, Cerebral Artery Embolism, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Floxacillin Sodium
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from Netherlands on 2012-08-07
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Multi-Organ Failure, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Sepsis, Lung Infection
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 220 mg, unk
Indication: Haematological Malignancy
Start date: 2012-01-21
End date: 2012-01-23
Clofarabine
Dosage: 18 mg (10mg/m2), unk
Start date: 2012-01-18
End date: 2012-01-22
Clofarabine
Dosage: 19.5 mg x 1, day 1-5
Indication: Haematological Malignancy
Start date: 2011-11-16
End date: 2011-11-20
Cytarabine
Dosage: 390 mg x 1, day 1-7
Indication: Haematological Malignancy
Start date: 2011-11-16
End date: 2011-11-22
Cytarabine
Dosage: 1800 mg x2
Start date: 2012-01-18
End date: 2012-01-23
Idarubicin HCL
Dosage: 24 mg x 1, day 1-3
Indication: Haematological Malignancy
Start date: 2011-11-16
End date: 2011-11-18
Other drugs received by patient: Valaciclovir; Propofol; Amphotericin B; Valaciclovir
Possible Cytarabine side effects in female
Reported by a physician from United Kingdom on 2012-08-07
Patient: female
Reactions: Sepsis, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-21
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-22
Dexamethasone
Dosage: 40mg every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-21
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-20
Possible Cytarabine side effects in male
Reported by a physician from Belgium on 2012-08-06
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Cerebral Artery Embolism, Pericarditis, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Floxacillin Sodium
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in 66 year old male
Reported by a physician from United States on 2012-07-31
Patient: 66 year old male
Reactions: Sepsis, Melaena, Renal Failure Acute, Decreased Appetite
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 3360 mg, (total)
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-24
Daunorubicin HCL
Dosage: 435 mg, (total)
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-24
Sprycel
Dosage: 1200 mg, (total)
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-24
End date: 2012-06-12
Possible Cytarabine side effects in 40 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31
Patient: 40 year old female, weighing 96.2 kg (211.6 pounds)
Reactions: Left Ventricular Dysfunction, Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1.0g/m2
Start date: 2012-06-19
End date: 2012-06-25
Idarubicin HCL
Dosage: 8 milligram/sq. meter
Start date: 2012-06-19
End date: 2012-06-25
Revlimid
Dosage: 30 milligram
Administration route: Oral
Start date: 2012-06-19
End date: 2012-07-04
Other drugs received by patient: Amiodarone HCL; Antibiotics; Labetalol HCL; Antibiotics
Possible Cytarabine side effects in 24 year old female
Reported by a consumer/non-health professional from United States on 2012-07-30
Patient: 24 year old female, weighing 51.0 kg (112.2 pounds)
Reactions: Abdominal Pain, Hyperkalaemia, Disseminated Intravascular Coagulation, Gastrointestinal Necrosis, Acidosis, Nephrolithiasis, Skin Discolouration, Ecchymosis, Clostridial Infection, Emphysema, White Blood Cell Count Decreased, Hypotension, Anaemia, Condition Aggravated, Soft Tissue Infection, Sepsis, Flank Pain, Colitis, Cardiac Arrest, Sinus Tachycardia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: last dose on 16jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Cytarabine
Dosage: last dose:17jun12 route:intra ommya
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Dexamethasone
Dosage: last dose:16jun12
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Doxorubicin HCL
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Filgrastim
Dosage: last dose:18jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
End date: 2012-01-01
Leucovorin Calcium
Dosage: last dose :21may12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Mesna
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Methotrexate
Dosage: last dose:13jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Methylprednisolone
Dosage: last dose:21may12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Sprycel
Dosage: last dose on 26jun12
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Vincristine Sulfate
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Possible Cytarabine side effects in 44 year old female
Reported by a physician from France on 2012-07-27
Patient: 44 year old female
Reactions: Lung Disorder, Gastrointestinal Haemorrhage, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia
Drug(s) suspected as cause:
Cerubidine
Dosage: 104.4 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-22
End date: 2008-07-24
Cytarabine
Dosage: 348 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-22
End date: 2008-07-28
Mylotarg
Dosage: 10.4 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-25
End date: 2008-07-25
Possible Cytarabine side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-27
Patient: female
Reactions: Iatrogenic Injury, Ischaemic Stroke, Candida Sepsis, Coma, Status Epilepticus, Aplasia, Convulsion, Subarachnoid Haemorrhage, Sepsis, Posterior Reversible Encephalopathy Syndrome, Oedema, Bone Marrow Failure, Candidiasis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 40 mg, unk
Start date: 2012-05-24
Cytarabine
Dosage: 40 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-07
End date: 2012-05-24
Cytarabine
Dosage: 40 mg, unk
Start date: 2012-05-17
Imatinib Mesylate
Dosage: 400 mg, daily
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-10
End date: 2012-05-26
Methotrexate
Dosage: 15 mg, unk
Start date: 2012-05-24
Methotrexate
Dosage: 15 mg, unk
Start date: 2012-05-17
Methotrexate
Dosage: 15 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-07
Other drugs received by patient: Aspegic 1000; Flagyl; Clonazepam; Fluconazole; Zyvox; Trandate; Amphotericin B; Depakene; Keppra; Idarubicin HCL; Olmesartan Medoxomil and Hydrochlorothizide; Metformin Hydrochloride; Fenofibrate; Vincristine; Vincristine; Vancomycin; Aspegic 1000; Bactrim DS; Mesna; Colimycine; Vibramycin D; Fluconazole; Cyclophosphamide; Cyclophosphamide; Tazobactam; Pyostacine; Idarubicin HCL; Methylprednisolone; Ciprofloxacin Hydrochloride; Heparin Sodium; Idarubicin HCL; Ventolin; Valacyclovir Hydrochloride; Mesna; Amikacin; Imipenem and Cilastatin Sodium; Vfend; Idarubicin HCL; Vincristine; Gentamicin; Rocephin; Fosphenytoin Sodium
Possible Cytarabine side effects in 17 year old male
Reported by a physician from United States on 2012-07-26
Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)
Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Pulmonary Oedema, Acute Respiratory Distress Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: 1000 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-27
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Daunorubicin Hydrochloride
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-26
Possible Cytarabine side effects in female
Reported by a physician from France on 2012-07-25
Patient: female, weighing 77.0 kg (169.4 pounds)
Reactions: Abdominal Pain, Confusional State, Chills, Pyrexia, Convulsion, Loss of Consciousness, Cerebral Hypoperfusion, Diarrhoea, Gamma-Glutamyltransferase Increased, Sepsis
Drug(s) suspected as cause:
Clofarabine
Dosage: 54.5 mg, on d2-d3-d4-d5 and d6
Indication: Acute Leukaemia
Start date: 2012-06-26
End date: 2012-06-30
Cytarabine
Dosage: 1825 mg, on d1-d2-d3-d4-and d5
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
End date: 2012-06-29
Filgrastim
Dosage: 385 mg, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-05
Other drugs received by patient: Plitician; Ambiosome; Actrapid; Magnesium Sulfate; Aluminum Hydroxide and Magnesium Trisilicate; Decan; Plitician; Acetaminophen; Cernevit-12; Miconazole; Tiorfan; Zofran
Possible Cytarabine side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-25
Patient: female, weighing 88.0 kg (193.6 pounds)
Reactions: Enterobacter Infection, Gamma-Glutamyltransferase Increased, Diarrhoea, Nausea, Sepsis, Oxygen Supplementation, Epilepsy, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: unk
Indication: Acute Leukaemia
Cytarabine
Dosage: unk
Indication: Acute Leukaemia
Filgrastim
Dosage: unk
Indication: Product Used FOR Unknown Indication
Possible Cytarabine side effects in 63 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23
Patient: 63 year old male
Reactions: Fatigue, Diarrhoea, Acute Myeloid Leukaemia, Bone Pain, Sepsis, Asthenia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Indication: Acute Myeloid Leukaemia
Daunorubicin HCL
Indication: Acute Myeloid Leukaemia
Oxaliplatin
Dosage: 85 mg/m2 on days 1, 15, 29
Indication: Oesophageal Carcinoma
End date: 2007-02-01
Other drugs received by patient: Capecitabine
Possible Cytarabine side effects in female
Reported by a physician from United Kingdom on 2012-07-16
Patient: female
Reactions: Sepsis, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-21
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-22
Dexamethasone
Dosage: 40mg every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-21
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-20
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-07-16
Patient: female, weighing 108.8 kg (239.4 pounds)
Reactions: Bronchopulmonary Aspergillosis, Haemoptysis, Haemorrhage Intracranial, Transfusion Reaction, Genital Rash, Mucosal Inflammation, Diarrhoea, Respiratory Failure, Sepsis, Liver Function Test Abnormal
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Other drugs received by patient: Allopurinol; Platelets; Biotene; Carvedilol; Docusate; Hydroxyurea; Neupogen; Acyclovir; Oxycodone HCL; Oxycontin; Bactrim; Albuterol; Omeprazole; Spiriva; Multi-Vitamin
Possible Cytarabine side effects in 44 year old female
Reported by a physician from France on 2012-07-13
Patient: 44 year old female
Reactions: Gastrointestinal Haemorrhage, Lung Disorder, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia
Drug(s) suspected as cause:
Cerubidine
Dosage: 104.4 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-22
End date: 2008-07-24
Cytarabine
Dosage: 348 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-22
End date: 2008-07-28
Mylotarg
Dosage: 10.4 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-25
End date: 2008-07-25
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from Belgium on 2012-07-11
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Neutropenic Colitis, Ileus, Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 10 mg/m2, qod, on days 2, 4, 6, 8, 10
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-05
End date: 2012-01-13
Cytarabine
Dosage: 200 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-04
End date: 2012-01-13
Idarubicin Hydrochloride
Dosage: 10 mg/m2, qod, on days 1, 3, 5
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-04
End date: 2012-01-08
Other drugs received by patient: Ceftazidime; Cefuroxime; Valacyclovir Hydrochloride; Allopurinol; Vfend; Colistin
Possible Cytarabine side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 300 mg/m2
Cyclophosphamide
Dosage: 250 mg/m2, bid for six doses
Indication: non-Hodgkin's Lymphoma
Cytarabine
Dosage: 100 mg/m2, daily x 5 days
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Dosage: 30 mg/m2, single
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Dosage: 60 mg/m2, single
Hydrocortisone Acetate
Dosage: given with methotrexate
Indication: non-Hodgkin's Lymphoma
Hydrocortisone Acetate
Dosage: given with cytarabine
Methotrexate
Dosage: 3000 mg/m2, single
Methotrexate
Dosage: given with hydrocortisone twice x 2
Indication: non-Hodgkin's Lymphoma
Methotrexate
Dosage: 1500 mg/m2, single
Prednisolone
Dosage: 60 mg/m2, daily for 5 days then tapered over 3 days
Indication: non-Hodgkin's Lymphoma
Prednisolone
Dosage: 60 mg/m2, daily for 7 days
Rituximab
Dosage: 1875 mg/m2, every 2-4 weeks for 5 total doses
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: 2 mg/m2, single
Vincristine
Dosage: 1 mg/m2, single
Indication: non-Hodgkin's Lymphoma
Possible Cytarabine side effects in 17 year old male
Reported by a physician from United States on 2012-07-09
Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)
Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Acute Respiratory Distress Syndrome, Pulmonary Oedema
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: 100 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: 1000 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Daunorubicin Hydrochloride
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-26
Possible Cytarabine side effects in 75 year old male
Reported by a physician from Germany on 2012-07-06
Patient: 75 year old male, weighing 81.0 kg (178.2 pounds)
Reactions: Sepsis
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cytarabine
Start date: 2012-05-22
End date: 2012-05-26
Etoposide
Idarubicin HCL
Lenograstim
Vidaza
Possible Cytarabine side effects in 77 year old male
Reported by a consumer/non-health professional from Japan on 2012-07-06
Patient: 77 year old male, weighing 57.0 kg (125.4 pounds)
Reactions: Sepsis, Circulatory Collapse, Febrile Neutropenia, Pancytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-19
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-19
Oncovin
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-08-23
End date: 2010-08-30
Pinorubin
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-08-23
End date: 2010-08-25
Prednisolone
Dosage: 10mg/day 28may10-19aug10,23aug10-31aug10
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-31
Sprycel
Dosage: 70mg 2/1d 28jun-05jul 50mg 1/1d 06jul-22aug10 reduced 140mg to 50mg
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-28
End date: 2010-08-22
Other drugs received by patient: Lasix; Sodium Bicarbonate; Neutrogin; Diamox; Famotidine; Pursennid
Page 1 Next >>
|
